Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Cancer|July 1, 1996
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trialG P Ianniello, G De Cataldis, P Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancerG Frasci, P Comella, M Rinaldo, et al.
Oncology|March 13, 2001
Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology GroupP Comella, M Biglietto, R Casaretti, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignanciesP Comella, G Palmieri, V Lorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanomaP Comella, A Daponte, R Casaretti, et al.
British Journal of Cancer|June 1, 2006
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II studyA Avallone, P Delrio, C Guida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, E Massa, L Manzione, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trialP Comella, G Frasci, N Panza, et al.
British Journal of Cancer|May 5, 2001
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II studyG Frasci, G Nicolella, P Comella, et al.
Pageof 9